Texas Oncology - McKinney
Mckinney, Texas, United States
Cancer treatment center in McKinney, Texas
5236 W University Dr Suite 1000, McKinney, TX 75071
About Texas Oncology - McKinney
"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Hoffmann-La Roche
2
NRG Oncology
2
National Cancer Institute (NCI)
2
Pfizer
2
Agendia
1
Alliance for Clinical Trials in Oncology
1
Amgen
1
Biotheranostics, Inc.
1
CanBas Co. Ltd.
1
Celcuity, Inc.
1
Clinical Trials at Texas Oncology - McKinney
During the past decade, Texas Oncology - McKinney conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
2009-11-17
2023-12-31
Active, not recruiting
545
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
2011-07-01
2031-07-01
Active, not recruiting
2,592
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
2014-02-07
Active, not recruiting
2,012
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
2015-07-01
2023-11-01
Recruiting
782
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
2015-09-01
2021-07-21
Completed
1,504
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
2016-12-01
2023-09-01
Active, not recruiting
276
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
2017-04-28
2037-12-01
Recruiting
25,000
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
2017-07-12
2029-06-24
Active, not recruiting
5,637
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Oncology - McKinney" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "NRG Oncology" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "Pfizer"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - McKinney"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Texas Oncology - McKinney
According to Clinical.Site data, the most researched conditions in "Texas Oncology - McKinney" are
"Breast Cancer" (4 trials), "Early Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Neoplasm Metastasis" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Texas Oncology - McKinney" in a lesser frequency.
Clinical Trials Intervention Types at Texas Oncology - McKinney
Most popular intervention types in "Texas Oncology - McKinney" are "Drug" (19 trials), "Radiation" (6 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (4 trials), "Fulvestrant" (3 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials) and "Laboratory Biomarker Analysis" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Oncology - McKinney
The vast majority of trials in "Texas Oncology - McKinney" are
23 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Texas Oncology - McKinney
Currently, there are NaN active trials in "Texas Oncology - McKinney".
undefined are not yet recruiting,
10 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Texas Oncology - McKinney,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Oncology - McKinney, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".